Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odanacatib in Men with Osteoporosis
NCT01120600Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of odanacatib in osteoporosis, sponsored by Merck & Co.. Started Jun 2010; status: completed.
02
Drugs
odanacatib
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01120600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120600.